Pharmagreen Biotech is raising funds on Dalmore Group through Reg A+ crowdfunding. The company aims to use innovative tissue culture technology for the preservation of plant species. Pharmagreen Biotech uses tissue culture science to make the highest quality, disease-free, and genetically same plantlets of high CBD hemp. The optimised plant growth technology of Pharmagreen eliminates disease and contamination, reduces growing time, and assures high-quality products. Peter Wojcik founded Pharmagreen Biotech in 2007. The current crowdfunding campaign has no minimum target and a maximum target of $7,500,000. The campaign proceeds will be used for real property lease or acquisition, equipment, construction costs, working capital, and general and administrative expenses.